Adenocarcinoma Lung Cancer Completed Phase 2 Trials for Ceritinib (DB09063)

IndicationStatusPhase
DBCOND0072925 (Adenocarcinoma Lung Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs